Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Sarepta Therapeutics (SRPT)

30.85 -1.64 (-5.05%)

5/25/2017  4:00pm

Open:

32.50

Pre. Close:

32.49

High:

32.95

Low:

30.35

Volume:

2,627,132

Market Cap:

1.70B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

33.1 - 34.14

34.14 - 35

Low:

28.5 - 29.32

29.32 - 29.99

Close:

29.63 - 31.01

31.01 - 32.16

Technical analysis  (as of: 2017-05-25 4:50:37 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 41.94     One year: 45.95

Support:

Support1: 30.35    Support2: 25.25

Resistance:

Resistance1: 35.91    Resistance2: 39.34

Pivot:

33.43

Moving Averages:

MA(5): 32.59     MA(20): 33.90

MA(100): 31.58     MA(250): 32.18

MACD:

MACD(12,26): 0.03     Signal(12,26,9): 0.49

%K %D:

%K(14,3): 16.24     %D(3): 21.90

RSI:

RSI(14): 39.65

52-Week:

High: 63.73  Low: 14.83  Change(%): 45.6

Average Vol(K):

3-Month: 185701  10-Days 68838

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SRPT has closed above bottom band by 0.7%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 25 May 2017 17:03:45 GMT
For Sarepta Therapeutics, Inc. (SRPT), The Evidence Is In The Technical Chart

Sat, 06 May 2017 11:23:01 GMT
Sarepta Therapeutics Inc. Stock Rose 22.5% in April. Here's Why.

Fri, 28 Apr 2017 04:07:30 GMT
Sarepta Therapeutics' (SRPT) CEO Ed Kaye On Q1 2017 Results - Earnings Call ...

Thu, 25 May 2017 20:26:15 GMT
Sarepta Therapeutics Inc (SRPT) Cut to "Buy" at Vetr Inc.

Mon, 22 May 2017 20:55:28 GMT
Why Zoe's Kitchen, GOL, and Sarepta Therapeutics Slumped Today

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

51.41

% Held by Insiders

7.79

% Held by Institutions

61.20

Shares Short (K)

10470

Shares Short Prior Month (K)

9520

Stock Financials

EPS

-2.420

EPS Est. Current Year

-0.940

EPS Est. Next Year

-1.620

EPS Est. Next Quarter

-0.620

Forward EPS

Book Value (p.s.)

7.810

PEG Ratio

187.95

Profit Margin

Operating Margin

-4830.75

Return on Assets (ttm)

-46.9

Return on Equity (ttm)

-101.4

Qtrly Rev. Growth

332.6

Gross Profit (p.s.)

0.097

Sales Per Share

0.099

EBITDA (p.s.)

-4.690

Qtrly Earnings Growth

Operating Cash Flow (M)

-245.82

Levered Free Cash Flow (M)

-148.23

FoxReading.com

Valuation

P/E

-12.75

P/E Growth Ratio

-0.05

P/BV

3.95

P/S

311.97

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-07-12

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.